Flibanserin (Addyi®) vs. Flibanserin and Sex Therapy
Status:
Terminated
Trial end date:
2019-01-30
Target enrollment:
Participant gender:
Summary
Unblinded study of flibanserin for 8 weeks with responders randomized 1:1 to receive study
medication alone vs. study medication and sex therapy for 12 additional weeks.